Can You Get Tirzepatide for $129 per Month? Verified Pricing & Gaps

Last reviewed: September 14, 2026 Last updated: September 14, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Yes—but usually only at the starting dose or for a single introductory month. We verified every program that advertises tirzepatide at or below $150 per month. Mochi Health offers compounded tirzepatide starting dose for $90 in medication plus $39 in membership, totaling $129 per month at the lowest tier; higher doses cost more. Noom Med advertises microdose GLP-1Rx at $79 for the first month, then $179 monthly. BrightMeds offers a three-month prepaid tirzepatide plan at $119 per month effective ($357 upfront), then $149 monthly. AltRx advertised a promotional twelve-month prepaid plan at $125 per month effective ($1,500 upfront), ending September 5, 2026. In each case the advertised figure either applies to the starting dose, requires a multi-month prepayment, or jumps substantially at refill. Standard ongoing tirzepatide programs without dose tiers or introductory discounts run $249–$399 per month.

At-a-glance: advertised versus ongoing rates

All figures verified at the dates shown; every price includes medication, clinician care, and shipping unless noted otherwise. Membership fees are itemized separately where they apply. None of the programs above are offered by PlexusDx.

Normalized twelve-month cost: true recurring economics

When you separate introductory discounts, starting-dose-only pricing, and prepaid commitment periods from standard refill rates, the twelve-month cost picture looks different. The table below assumes you remain at the provider's standard tirzepatide option (not microdose, not semaglutide) for a full year, using publicly advertised or checkout-verified figures where available.

Twelve-month totals are our calculation, combining advertised or verified intro rates, refill rates, and any mandatory membership fees. Figures assume continuous enrollment and standard tirzepatide (not microdose or semaglutide alternatives). Mochi Health and Noom Med are excluded because their lowest advertised rates apply to microdose or starting-dose tiers that do not reflect full-dose tirzepatide over twelve months. Confirm all pricing at checkout before committing.

Why the advertised $129 rate carries trade-offs

Mochi Health offers the clearest path to a $129 monthly total: $90 for tirzepatide medication at the starting dose plus a $39 monthly membership. The model is dose-tiered—medication cost increases as you titrate. If your clinician prescribes a higher maintenance dose, your monthly bill will rise above $129. The membership fee continues regardless of dose. Mochi Health holds a 4.5-star rating on Trustpilot across approximately 18,000 reviews (captured September 4, 2026; trustpilot.com). One verified one-star review reported a provider appearing late to a video visit and not engaging (captured September 4, 2026; trustpilot.com). No systematic delay or service-reliability themes emerged in our indexed review pass, but dose-tier economics mean the $129 figure is a floor, not a ceiling.

Noom Med advertises microdose GLP-1Rx at $79 for the first month (a three-week subscription plus four weeks of medication), then $179 per month for a twelve-week subscription. The microdose program may titrate more slowly than standard protocols. Noom Med holds a 4.5-star Trustpilot rating across approximately 67,000 profile-wide reviews (not GLP-1-specific; captured September 4, 2026; trustpilot.com). One Reddit complaint captured in our review pass cited slow titration and perceived lack of efficacy (captured September 4, 2026). If you require faster dose escalation or prefer a standard tirzepatide titration schedule, the microdose structure and the $179 recurring cost may not align with your goals.

BrightMeds offers a three-month prepaid tirzepatide plan at $357 ($119 per month effective, our calculation), then $149 monthly after the initial term. The rate applies to any dose—no tier pricing. No membership fee is advertised. The three-month prepayment reduces flexibility: you commit $357 upfront, and if you need to pause or switch providers in month one or two, refund terms become critical. BrightMeds pricing was verified via public plan grid (captured September 4, 2026).

AltRx advertised a promotional twelve-month prepaid tirzepatide plan at $125 per month effective ($1,500 upfront, our calculation), with the promotion stated to end September 5, 2026 (captured September 4, 2026). If the promotion is still available when you read this, the twelve-month lock-in is the longest commitment we verified. The monthly rate after prepay is $149. If your response to tirzepatide is uncertain or you anticipate needing to adjust compounds or routes mid-year, a twelve-month prepaid plan carries higher switching cost.

OrderlyMeds advertises a two-month starter at $299 ($149.50 per month effective, our calculation), then $299 monthly. The jump from $149.50 to $299 is the steepest refill increase we verified among programs claiming sub-$150 introductory rates. OrderlyMeds holds a 3.6-star Trustpilot rating across approximately 634 reviews (captured September 4, 2026; trustpilot.com). Captured one-star and two-star reviews report fast initial charging but slow refunds, non-response to customer inquiries, delayed shipping, unannounced pharmacy changes, and unwanted calls or texts after opt-out requests (captured September 4, 2026; trustpilot.com). While no single anecdote defines a program, the combination of the lowest Trustpilot score in this comparison, multiple service-reliability complaints, and the largest intro-to-refill price jump warrants attention.

Programs with dose-blind, no-intro-rate pricing

If you prefer a consistent monthly cost with no starting-dose limitation and no introductory-rate expiration, three checkout-verified programs offer dose-blind tirzepatide pricing without separate membership fees: PlexusDx ($289 month-to-month, $269 on three-month commitment, $249 on six-month commitment; captured September 14, 2026; internal pricing data September 4, 2026), Embody ($349 per month; captured July 17–23, 2026), and Peak Wellness ($349 month-to-month, with lower per-month rates on six-month prepaid plans; captured July 17–23, 2026). Each charges the same rate regardless of dose. Found offers cash-pay tirzepatide at $359 per month or $169 per month effective when twelve months are prepaid at $2,028 (captured September 4, 2026); compounded medication is included in the stated rate, and Found holds a 4.1-star Trustpilot rating across approximately 732 reviews (captured September 4, 2026; trustpilot.com).

MEDVi charges $279 for the first month, then $399 for every refill (captured September 4, 2026). MEDVi holds a 4.3-star Trustpilot rating across approximately 15,000 reviews (captured September 4, 2026; trustpilot.com). The first-month discount is modest, and the $399 refill rate is among the highest we verified. TrimRx advertises tirzepatide at $349 but verifies at $399 per month ongoing at checkout, with lower per-month rates on three-, six-, and twelve-month prepaid plans (captured July 17–23, 2026).

Choose a starting-dose or intro-rate program if…

• You expect to remain at a lower maintenance dose for an extended period, making Mochi Health's tier model economically favorable.
• You are exploring microdose GLP-1 as a deliberate, slower-titration strategy and the $179 recurring Noom Med rate fits your budget.
• You are comfortable prepaying three months ($357 at BrightMeds) or twelve months ($1,500 at AltRx, if the promotion remains available) and do not anticipate needing to pause or switch providers mid-term.
• You accept that advertised introductory rates expire or escalate, and you have verified refund and cancellation terms in writing before committing.

Choose a dose-blind, no-intro-rate program if…

• You want predictable monthly costs that do not increase when your clinician raises your dose.
• You prefer no introductory-rate expiration and no pricing surprises at refill.
• You value the flexibility to cancel a month-to-month plan or accept a shorter commitment term (three or six months) for a lower rate without a twelve-month lock-in.
• You want to avoid juggling a separate membership fee and per-dose medication charge.

Where PlexusDx fits

PlexusDx offers compounded tirzepatide injection at $289 per month on a month-to-month plan, $269 per month on a three-month commitment, or $249 per month on a six-month commitment (captured September 14, 2026; internal pricing data September 4, 2026). The rate is the same at every dose—no tier pricing, no introductory discount, no refill jump. Every plan includes the medication, clinician care, and shipping; there is no separate membership fee. Month-to-month plans cancel anytime; multi-month commitments carry a term obligation. PlexusDx works with licensed 503A compounding pharmacies. PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com).

If you prefer a single predictable rate with no starting-dose ceiling and no intro-to-refill surprise, PlexusDx delivers dose-blind economics at a lower ongoing cost than Embody, Peak Wellness, MEDVi, or TrimRx. If you require the absolute lowest first-month or starting-dose rate and are prepared to manage tier pricing or prepaid commitments, Mochi Health, BrightMeds, or AltRx may offer a lower entry point—with the trade-offs detailed above.

Methodology and freshness

Pricing data for PlexusDx were captured September 14, 2026 (this article) and verified against internal pricing records dated September 4, 2026. Competitor pricing, including advertised introductory rates, standard refill rates, membership fees, and prepaid-plan structures, was verified between July 17 and September 4, 2026, via public pricing pages and, where possible, checkout flows. Programs marked "checkout-verified" reached a payment or final-confirmation screen; programs marked "advertised" or "partial verification" were documented from public-facing pages or intake flows that gated final pricing behind contact steps. Trustpilot ratings and review volumes were captured September 4 or September 9, 2026, and reflect profile-wide figures unless noted as product-specific. Twelve-month cost calculations are our own, combining verified intro rates, refill rates, and any mandatory recurring fees; all such figures are labeled "our calculation." Promotional rates (AltRx twelve-month prepaid) carried a stated end date of September 5, 2026; confirm availability at checkout. Where evidence conflicts—such as TrimRx's $349 advertised versus $399 checkout-verified rate, or Henry Meds' internal copy inconsistency describing a three-month plan as "delivered every 60 days for 6 months"—we state the conflict plainly and advise confirming the figure at checkout. No pricing data for any provider were invented, estimated, or derived by discount arithmetic; every published figure is either a direct observation or an explicitly labeled calculation from observed rates.

Frequently Asked Questions

Is a $129 tirzepatide plan available without dose restrictions?

Mochi Health offers tirzepatide starting dose at $90 medication plus $39 membership ($129 total per month), but medication cost rises as your clinician increases your dose. No provider we verified offers full-dose, dose-blind tirzepatide at $129 per month. Dose-blind programs typically charge $249–$399 per month.

Do introductory tirzepatide rates apply to refills?

No. MEDVi charges $279 for the first month, then $399 monthly. OrderlyMeds charges $149.50 effective for two months prepaid, then $299 monthly. Noom Med charges $79 for the first month of microdose GLP-1Rx, then $179 monthly. Always confirm the refill rate in writing before starting.

What happens if I prepay and need to pause mid-term?

Refund and pause policies vary by provider. BrightMeds requires $357 upfront for three months; AltRx's promotional plan requires $1,500 upfront for twelve months. Review each provider's cancellation and refund terms in writing before prepaying, and confirm whether pausing resets your rate or forfeits prepaid months.

Does PlexusDx charge more as my dose increases?

No. PlexusDx tirzepatide injection is $289 per month month-to-month, $269 per month on a three-month commitment, or $249 per month on a six-month commitment, at every dose. The rate does not change when your clinician adjusts your prescription. No separate membership fee applies.

Are compounded tirzepatide medications FDA-approved?

Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies. Compounded tirzepatide is not the same as branded Mounjaro or Zepbound.

Sources

• PlexusDx internal pricing data (captured September 4, 2026; verified September 14, 2026)
• Mochi Health public pricing page (captured September 4, 2026)
• Noom Med public plan offers (captured September 4, 2026)
• BrightMeds public plan grid (captured September 4, 2026)
• AltRx promotional pricing grid (captured September 4, 2026)
• OrderlyMeds advertised pricing (captured September 4, 2026)
• Found cash-pay and insurance-support plan pages (captured September 4, 2026)
• MEDVi checkout-verified pricing (captured September 4, 2026)
• Embody checkout-verified pricing (captured July 17–23, 2026)
• Peak Wellness checkout-verified pricing (captured July 17–23, 2026)
• TrimRx checkout-verified pricing (captured July 17–23, 2026)
• ShedRx product page (captured September 4, 2026)
• Amble FAQ hosted on Canva (captured September 4, 2026)
• Henry Meds product page (captured September 4, 2026)
• Trustpilot profiles: PlexusDx (captured September 9, 2026), Mochi Health, Noom Med, OrderlyMeds, MEDVi, Found (all captured September 4, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.